You must log in to view this page.

Madrigal Pharmaceuticals Inc.

NASDAQ: MDGL
Share price (3/25/25): $343.29
Market cap (3/25/25): $7.580 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement

Prospectus supplement for primary offering

Automatic shelf registration

Prospectus supplement for primary offering

Ownership Filter

News Filter

Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors

Reports Fourth-Quarter and Full-Year 2024 Financial Results and Announces New Two-Year Data Demonstrating Potential Benefit of Rezdiffra™ (Resmetirom) in Patients With Compensated MASH Cirrhosis

Announces Preliminary* Fourth-Quarter and Full-Year 2024 Net Sales, Year-End Cash and Total Patients on Rezdiffra

Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates

Reports Second-Quarter 2024 Financial Results and Provides Corporate Updates

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC